dual CD20/CD19-targeted cell therapy — Initial data
H2 2026
First-in-human data expected starting in the second half of 2026.Source filing
catalyst calendar
LEGEND BIOTECH CORP · Data as of 2026-10-25
H2 2026
First-in-human data expected starting in the second half of 2026.Source filing
2H 2026
• Present in vivo dataSource filing